These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33726828)

  • 1. Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial.
    Siddharthan T; Pollard SL; Jackson P; Robertson NM; Wosu AC; Rahman N; Padalkar R; Sekitoleko I; Namazzi E; Alupo P; Hurst JR; Kalyesubula R; Dowdy D; Wise R; Barnes PJ; Checkley W; Kirenga B
    Trials; 2021 Mar; 22(1):213. PubMed ID: 33726828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
    Devereux G; Cotton S; Barnes P; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Fielding S; Gompertz S; Haughney J; Lee AJ; McCormack K; McPherson G; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Trials; 2015 Jun; 16():267. PubMed ID: 26058585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocol.
    Siddharthan T; Pollard SL; Quaderi SA; Mirelman AJ; Cárdenas MK; Kirenga B; Rykiel NA; Miranda JJ; Shrestha L; Chandyo RK; Cattamanchi A; Michie S; Barber J; Checkley W; Hurst JR;
    Trials; 2018 Oct; 19(1):571. PubMed ID: 30340648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    JAMA; 2018 Oct; 320(15):1548-1559. PubMed ID: 30326124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial.
    Jenkins CR; Wen FQ; Martin A; Barnes PJ; Celli B; Zhong NS; Zheng JP; Scaria A; Di Tanna GL; Bradbury T; Berend N;
    Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33334939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
    Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
    Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial.
    Bradbury T; Di Tanna GL; Scaria A; Martin A; Wen FQ; Zhong NS; Zheng JP; Barnes PJ; Celli B; Berend N; Jenkins CR;
    Int J Chron Obstruct Pulmon Dis; 2022; 17():273-282. PubMed ID: 35153479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis.
    Donohue JF; Kerwin E; Barnes CN; Moran EJ; Haumann B; Crater GD
    BMC Pulm Med; 2020 May; 20(1):134. PubMed ID: 32393215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
    Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
    Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial for the effect of Modified Shenling Baizhu Powder on delaying the illness progress of COPD stable phase patients (GOLD 1-2 stages): A study protocol.
    Liu Y; Xie X; Wang W; Zhao K; Xiao W; Xiao J; Chen J; Zeng J; Chen K
    Medicine (Baltimore); 2020 Oct; 99(43):e22700. PubMed ID: 33120762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
    Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
    Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional validation of the COPD Assessment Test (CAT) among chronic obstructive pulmonary disease patients in rural Uganda.
    Batte C; Semulimi AW; Mutebi RK; Twinamasiko N; Muyama SR; Mukisa J; Atukunda I; Mukunya D; Kalyesubula R; Trishul S; Kirenga B
    PLOS Glob Public Health; 2023; 3(6):e0002013. PubMed ID: 37276227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Obstructive Pulmonary Disease Self-Management in Three Low- and Middle-Income Countries: A Pilot Randomized Trial.
    Pollard SL; Siddharthan T; Hossen S; Rykiel NA; Flores-Flores O; Alupo P; Quaderi S; Ascencio I; Barber JA; Chandyo R; Das SK; Gianella G; Kirenga B; Grunstra K; Miranda JJ; Mohan S; Ricciardi F; Sharma AK; Shrestha L; Soares MO; Wosu AC; Hurst JR; Checkley W;
    Am J Respir Crit Care Med; 2023 Nov; 208(10):1052-1062. PubMed ID: 37698443
    [No Abstract]   [Full Text] [Related]  

  • 20. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
    Rutten-van Mölken MP; van Nooten FE; Lindemann M; Caeser M; Calverley PM
    Pharmacoeconomics; 2007; 25(8):695-711. PubMed ID: 17640111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.